BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8217819)

  • 1. Subclinical autonomic dysfunction in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
    Turner ML; Boland OM; Parker AC; Ewing DJ
    Br J Haematol; 1993 Aug; 84(4):623-6. PubMed ID: 8217819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lymphoma on the peripheral nervous system.
    Hughes RA; Britton T; Richards M
    J R Soc Med; 1994 Sep; 87(9):526-30. PubMed ID: 7932460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral nervous system and spinal cord involvement in lymphoma.
    Correale J; Monteverde DA; Bueri JA; Reich EG
    Acta Neurol Scand; 1991 Jan; 83(1):45-51. PubMed ID: 1849335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe jaundice, due to vanishing bile duct syndrome, as presenting symptom of Hodgkin's lymphoma, fully reversible after chemotherapy.
    Leeuwenburgh I; Lugtenburg EP; van Buuren HR; Zondervan PE; de Man RA
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):145-7. PubMed ID: 18188038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas.
    Lavey RS; Eby NL; Prosnitz LR
    Cancer; 1990 Jul; 66(1):80-8. PubMed ID: 2354413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.
    Rota Scalabrini D; Caravelli D; Carnevale Schianca F; D'Ambrosio L; Tolomeo F; Boccone P; Manca A; De Rosa G; Nuzzo A; Aglietta M; Grignani G
    BMC Res Notes; 2014 Aug; 7():529. PubMed ID: 25125318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hodgkin's lymphoma: sensitive and autonomic neuropathy as a paraneoplastic manifestation].
    Milanesio M; Vera S; Sturich AG; Guanchiale LA; Figueroa Bonaparte S; Basquiera AL
    Medicina (B Aires); 2023; 83(3):484-488. PubMed ID: 37379549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Thrombocytopenia Secondary to Hodgkin's Lymphoma in Children.
    Tanous O; Dujovny T; Hertzel G; Koren A; Levin C
    Isr Med Assoc J; 2020 Apr; 22(4):224-226. PubMed ID: 32286024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low grade non-Hodgkin's lymphoma after combined therapy for Hodgkin's disease].
    Raya Sánchez JM; González Brito G; Hernández Nieto L; Brito Barroso ML; Alvarez Argüelles H; Jorge Hernández JA; Martín Herrera A
    Sangre (Barc); 1994 Dec; 39(6):461-4. PubMed ID: 7855699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephrotic syndrome in Hodgkin's disease].
    Miltényi Z; Keresztes K; Ujhelyi L; Kovács J; Illés A
    Orv Hetil; 2005 Jun; 146(25):1357-60. PubMed ID: 16106759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's disease associated with neurologic paraneoplastic syndrome.
    Vickers SM; Niederhuber JE
    South Med J; 1997 Aug; 90(8):839-44. PubMed ID: 9258315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Hodgkin's lymphoma of the central nervous system after treatment of Hodgkin's disease.
    Miller DC; Knee R; Schoenfeld S; Wasserstrom WR; Karp G
    Am J Clin Pathol; 1989 Apr; 91(4):481-5. PubMed ID: 2929506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
    Sertoli MR; Santini G; Chisesi T; Congiu AM; Rubagotti A; Contu A; Salvagno L; Coser P; Porcellini A; Vespignani M
    J Clin Oncol; 1994 Jul; 12(7):1366-74. PubMed ID: 7517442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and non-Hodgkin's lymphoma.
    Radford JA; Clark S; Crowther D; Shalet SM
    Br J Cancer; 1994 Feb; 69(2):379-81. PubMed ID: 7507693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced refractory lymphomas with a combination of carmustine, bleomycin, teniposide, dexamethasone, and cisplatin (the BBVDD regimen). An ECOG pilot study.
    Spiers AS; Weens JH; Rowe JM; Smith TJ; Horton J; Gordon LI; Glick JH
    Am J Clin Oncol; 1991 Dec; 14(6):519-25. PubMed ID: 1720279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas.
    Tessoulin B; Thomare P; Delande E; Moynard J; Gastinne T; Moreau A; Bossard C; Mahé B; Blin N; Dubruille V; Touzeau C; Boudreault JS; Perrin F; Lok A; Guillaume T; Garnier A; Peterlin P; Gallas P; Chevallier P; Moreau P; Le Gouill S
    Ann Hematol; 2017 Jun; 96(6):943-950. PubMed ID: 28374163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
    Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT
    J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group.
    Santini G; De Souza C; Aversa S; Patti C; Tedeschi L; Candela M; Olivieri A; Chisesi T; Rubagotti A; Centurioni R; Nardi V; Congiu M; Gennaro M; Truini M;
    Braz J Med Biol Res; 2004 May; 37(5):719-28. PubMed ID: 15107935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.